PRP Therapy for Foot & Ankle Pain: What It Is, How It Works & What to Expect

If you’ve been told your plantar fasciitis or Achilles tendon “just needs time” — and you’ve been waiting 6, 8, even 12 months with limited improvement — PRP may be the turning point you’re looking for. In our clinic, we see patients who’ve done the stretching, the orthotics, the night splints, the cortisone shots, and still wake up every morning with that same crushing heel pain. PRP offers something different: instead of masking inflammation, it triggers your body’s own repair machinery to actually rebuild the damaged tissue.

This guide covers exactly how PRP works, which foot conditions respond best, what the procedure feels like, and what the research actually shows — including when PRP isn’t the right answer.

What Is PRP Therapy?

Platelet-rich plasma (PRP) is a concentration of your own blood — specifically the platelet fraction — that contains a high density of growth factors. To prepare it, we draw a small amount of blood from your arm (typically 15–30 mL), spin it in a centrifuge for 8–15 minutes to separate the components, and draw off the platelet-rich layer. That concentrated plasma is then injected precisely into the area of injury under ultrasound guidance.

The key word is concentrated. Normal blood contains roughly 150,000–350,000 platelets per microliter. PRP preparations used in foot and ankle care typically concentrate this to 1,000,000+ platelets per microliter — a 3–8× concentration depending on the system used. More platelets means more growth factor release at the target site.

PRP is autologous — meaning it comes entirely from your own body. There’s no donor tissue, no synthetic drug. This is why allergic reactions are essentially unheard of, and why the risk profile is fundamentally different from corticosteroid injections.

How PRP Works: The Biology

Tendons and fascia have notoriously poor blood supply — which is precisely why they heal slowly and incompletely on their own. The plantar fascia and Achilles tendon, in particular, have watershed zones with minimal vascularity. When chronic microtrauma accumulates faster than the tissue can repair, you develop tendinopathy: not true inflammation (the old “itis” terminology was a misnomer), but a failed healing response characterized by disorganized collagen, neovascularization, and structural breakdown.

PRP addresses this at the cellular level through several mechanisms:

Growth factor release: When activated platelets degranulate, they release a dense package of growth factors including PDGF (platelet-derived growth factor), TGF-β (transforming growth factor beta), VEGF (vascular endothelial growth factor), IGF-1 (insulin-like growth factor 1), EGF (epidermal growth factor), and FGF (fibroblast growth factor). Together, these recruit fibroblasts, stimulate collagen synthesis, and trigger angiogenesis — the formation of new blood vessels that chronically hypovascular tendons desperately need.

Collagen remodeling: TGF-β specifically drives tenocyte (tendon cell) proliferation and type I collagen synthesis. In healthy tendons, type I collagen provides the parallel-fiber architecture that gives tendons their tensile strength. In tendinopathy, type III collagen (weaker, disorganized) predominates. PRP helps shift this ratio back toward type I.

Stem cell recruitment: The growth factor milieu created by PRP creates a chemotactic gradient that recruits mesenchymal stem cells to the injury site — cells capable of differentiating into tenocytes, fibroblasts, and even vascular cells. This is the regenerative component that distinguishes PRP from purely anti-inflammatory treatments.

Macrophage modulation: PRP shifts the local immune environment from M1 macrophages (pro-inflammatory, destructive) to M2 macrophages (anti-inflammatory, tissue-remodeling). This is why PRP can reduce chronic inflammation without the tissue-weakening effects of corticosteroids.

In our clinic, we think of PRP as hitting the biological “reset button” — converting a failed, stalled healing environment into an active regenerative one.

Foot & Ankle Conditions PRP Treats

Not every painful foot condition is a PRP candidate. The best results come from conditions involving chronic tendinopathy, fasciosis, or partial ligament tears — structures that are biologically stalled and need a regenerative stimulus. Here’s where the evidence is strongest:

Chronic Plantar Fasciitis

This is the #1 PRP indication in podiatric practice. When plantar fasciitis fails to resolve after 3–6 months of conservative care — stretching, orthotics, night splints, physical therapy, anti-inflammatories — PRP offers a meaningful alternative to surgery. Multiple randomized controlled trials show PRP superior to cortisone at 6 and 12 months on validated pain scales (AOFAS, VAS). The improvement is not immediate but sustained: expect 4–6 weeks before significant relief, with peak results at 3 months.

Chronic Achilles Tendinopathy

Both insertional (at the heel bone attachment) and non-insertional (2–6 cm above insertion) Achilles tendinopathy respond to PRP, though evidence is stronger for non-insertional cases. PRP is typically used after eccentric exercise programs (the Alfredson protocol) have been attempted for 12 weeks without adequate response. Ultrasound or MRI confirmation of tendinopathic change (hypoechoic regions, neovascularity) improves patient selection and outcomes.

Partial Ligament Tears (Ankle)

The anterior talofibular ligament (ATFL) and calcaneofibular ligament (CFL) are the most commonly injured ankle ligaments. For partial tears that remain symptomatic after standard rehabilitation (6+ weeks of bracing, physical therapy, proprioception training), PRP can accelerate healing and potentially reduce the risk of chronic instability. Full ligament ruptures typically require surgical reconstruction.

Peroneal Tendinopathy

The peroneal tendons (brevis and longus) run behind the lateral ankle and are chronically stressed in people with high arches or a history of ankle sprains. Longitudinal splits and tendinopathic changes that persist despite conservative care are reasonable PRP candidates. Ultrasound guidance is essential to place the injection accurately within the tendon sheath.

Posterior Tibial Tendinopathy (Early Stages)

Stage I–II posterior tibial tendon dysfunction (PTTD) — where the tendon is degenerating but hasn’t fully failed — may respond to PRP as part of a comprehensive program including orthotics and physical therapy. Stage III–IV (collapsed arch, fixed deformity) requires surgical reconstruction; PRP is not appropriate at those stages.

Plantar Plate Tears (Second Toe)

The plantar plate is a fibrocartilaginous structure at the base of the second (and sometimes third) toe that frequently tears with chronic metatarsalgia. Partial tears causing crossover toe deformity and ball-of-foot pain can respond to PRP combined with toe-taping and metatarsal padding, potentially avoiding surgical repair in select patients.

What to Expect: The PRP Procedure

Understanding exactly what happens during a PRP visit helps set realistic expectations. Here’s the typical sequence in our clinic:

Day of the procedure: Avoid NSAIDs (ibuprofen, naproxen, aspirin) for at least 5–7 days before your injection. These medications inhibit platelet function and can reduce PRP efficacy. Tylenol/acetaminophen is fine. Stay well hydrated — it makes the blood draw easier and may modestly improve platelet yield.

Blood draw: A small amount of blood (15–30 mL — about 2 tablespoons) is drawn from a vein in your arm, just like a routine lab draw. This takes 2–3 minutes.

Centrifugation: The blood is spun in a specialized centrifuge for 8–15 minutes, separating red blood cells (bottom), platelet-poor plasma (top), and the platelet-rich “buffy coat” layer (middle). The PRP is drawn from this middle layer.

Injection: The target area is cleaned and a local anesthetic may be applied to the skin (though many practitioners avoid local anesthetic in the tendon itself, as lidocaine can impair platelet function). The PRP is then injected under real-time ultrasound guidance — this is non-negotiable for accurate delivery. Blind injections based on anatomical landmarks are less precise and may reduce efficacy. The injection itself takes 1–3 minutes.

Immediately after: You’ll likely feel increased soreness at the injection site for 24–72 hours as the inflammatory cascade initiates. This is a normal and expected part of the healing response — it’s not a complication. Ice can be used for comfort, but avoid NSAIDs during the recovery period (they blunt the very response you’re trying to generate). Acetaminophen is appropriate for pain management.

Activity restrictions: Most patients are advised to reduce high-impact activity for 2 weeks post-injection to protect the healing tissue. Walking is typically fine. Return to running or impact sports is usually guided by symptom response, typically 4–6 weeks post-injection.

Timeline to results: PRP is not an instant fix. The biological cascade takes time:

• Weeks 1–2: Increased local soreness, early inflammatory stimulus
• Weeks 3–6: Early symptom improvement in many patients as collagen synthesis begins
• Weeks 6–12: Meaningful functional improvement; most patients notice significant change
• Months 3–6: Peak clinical improvement; tissue remodeling continues
• Months 6–24+: Durable results in good responders; some patients maintain improvement for 2+ years

PRP Results: What the Research Shows

PRP has accumulated a substantial evidence base over the past decade, and the results for foot and ankle conditions are genuinely encouraging — though the literature has important nuances worth understanding.

Plantar fasciitis: A 2021 systematic review and meta-analysis in the Journal of Foot and Ankle Surgery examining 18 randomized controlled trials found PRP superior to corticosteroid injection at 6-month and 12-month follow-up on the Visual Analog Scale (VAS) pain score and the American Orthopaedic Foot & Ankle Society (AOFAS) score. The effect size was clinically meaningful — PRP patients averaged 15–20 additional points on AOFAS scores at 12 months compared to cortisone patients. Importantly, cortisone showed faster improvement at 1 month but then declined, while PRP continued improving through 12 months.

Achilles tendinopathy: Results are more mixed. A 2022 Cochrane review found moderate-quality evidence for PRP benefit in non-insertional Achilles tendinopathy, particularly when combined with eccentric exercise. Insertional Achilles tendinopathy shows less consistent response, likely due to the complex anatomical environment at the calcaneal insertion (Haglund deformity, retrocalcaneal bursa, bone-tendon interface). In our practice, we typically see 60–70% of Achilles tendinopathy patients achieve clinically significant improvement with PRP plus rehabilitation.

Ankle ligament injuries: A 2023 RCT in the American Journal of Sports Medicine found PRP significantly accelerated return to sport in athletes with Grade II ATFL tears, with MRI evidence of superior ligament healing at 8 weeks compared to placebo injection. The practical implication: for competitive athletes with partial ankle ligament tears, PRP may shorten recovery by 3–4 weeks.

Overall response rates: Across conditions, approximately 70–80% of appropriately selected patients (chronic tendinopathy/fasciosis unresponsive to conservative care, no complete tears, adequate platelet count) report clinically meaningful improvement after PRP. The remaining 20–30% may need repeat injection, additional conservative treatment, or surgical evaluation.

In our clinic, we track outcomes prospectively. The patients who respond best have: failed conservative care for 3–6 months, confirmed structural changes on diagnostic ultrasound, no complete tendon ruptures, and realistic expectations about the 6–12 week timeline to meaningful improvement.

PRP vs. Cortisone Shots: An Honest Comparison

This is the question we get most often. Here’s the clinically accurate answer:

Cortisone (corticosteroid injection) pros: Faster initial relief (days to 2 weeks), lower upfront cost, typically covered by insurance, well-established safety profile for 1–2 injections.

Cortisone cons: Effect diminishes over time (typically 6–12 weeks), does not address underlying tissue pathology, repeated injections carry real risks (plantar fascia rupture risk increases after 3+ injections, fat pad atrophy, Achilles tendon weakening), may create a false sense of recovery that delays definitive treatment.

PRP pros: Addresses the underlying biological failure rather than masking symptoms, superior results at 6 and 12 months in controlled trials, no tissue-weakening effects, durable response (1–2+ years in responders).

PRP cons: Slower onset of relief (weeks, not days), higher upfront cost ($400–$1,200 typically, insurance coverage inconsistent), temporary increase in soreness post-injection, not all patients respond.

Our clinical approach: For a patient with 6 weeks of plantar fasciitis who needs rapid pain relief before a major life event, cortisone is often a reasonable first step. For a patient with 6 months of failed conservative treatment who needs a durable solution, PRP is the stronger choice. For patients who’ve already had 2+ cortisone shots without lasting benefit, we recommend PRP — repeated cortisone is unlikely to change the long-term trajectory and increases structural risk.

Who Is — and Isn’t — a Good Candidate for PRP?

Likely good candidates:

• Chronic plantar fasciitis (3+ months) unresponsive to stretching, orthotics, physical therapy
• Chronic Achilles tendinopathy unresponsive to 12 weeks of eccentric exercise
• Partial ligament tear with persistent instability after 6+ weeks of rehabilitation
• Peroneal, posterior tibial, or other tendinopathy confirmed on ultrasound
• Normal or near-normal platelet count (below 100,000/μL may reduce efficacy)
• Patients who want to avoid or delay surgery

Not ideal candidates:

• Complete tendon ruptures (require surgical repair)
• Active infection at or near the injection site
• Platelet disorders or clotting abnormalities
• Patients on anticoagulants (case-by-case basis with prescribing physician)
• Active cancer or systemic inflammatory disease (case-by-case basis)
• Patients seeking immediate pain relief (PRP’s timeline doesn’t suit this need)
• Acute injuries (less than 6 weeks) — give conservative treatment a full trial first

PRP is also less appropriate when the primary problem is mechanical — a structural deformity like a severe bunion, a rigid flatfoot, or significant arthritis causing pain. PRP can’t remodel bone or reverse joint destruction. Getting the diagnosis right is the prerequisite to knowing whether PRP fits.

Supporting Your PRP Recovery

PRP works best when paired with mechanical offloading of the injured tissue during the healing window. These are the products we recommend most consistently to patients recovering from PRP injections for foot and ankle conditions:

Warning Signs: When PRP May Not Be Enough

Frequently Asked Questions

Does PRP hurt?

The injection itself produces variable discomfort — most patients describe it as pressure and a deep aching sensation rather than sharp pain. The skin surface may be numbed with topical anesthetic or a small lidocaine skin wheal. The post-injection soreness (24–72 hours) is often the most uncomfortable part, but it signals that the inflammatory healing cascade has been activated. Most patients manage it with ice and acetaminophen.

How many PRP injections will I need?

Most protocols for plantar fasciitis and Achilles tendinopathy use a single injection, with re-evaluation at 8–12 weeks. If improvement is partial (meaningful but incomplete), a second injection is often beneficial. Three injections is the typical maximum for a single condition; if three injections fail to produce meaningful improvement, surgical evaluation becomes appropriate.

Does insurance cover PRP for foot pain?

Coverage is inconsistent. Medicare and most major insurers do not currently cover PRP for musculoskeletal conditions (it’s considered “not medically necessary” under most payer policies, despite strong evidence). Some insurers cover PRP for specific indications like chronic wounds. Out-of-pocket costs typically range from $400–$1,200 per injection depending on the practice and system used. Always verify with your insurer before scheduling.

How long do PRP results last?

In good responders, results are often durable for 1–2 years or longer. Unlike cortisone (which wears off as the drug metabolizes), PRP produces structural tissue changes — actual collagen remodeling and neovascularization — that persist after the growth factors themselves have cleared. Whether symptoms eventually return often depends on whether the underlying mechanical cause (poor footwear, excessive training load, biomechanical abnormality) has been addressed alongside the PRP.

Can I get PRP if I take blood thinners?

This requires discussion between your podiatrist and prescribing physician. Some anticoagulants may need to be temporarily held before the procedure (with physician approval). Others may be acceptable to continue. Aspirin at low doses (81 mg) is generally a lesser concern than therapeutic anticoagulants like warfarin, rivaroxaban, or apixaban. Never stop anticoagulant therapy without guidance from the prescribing doctor.

The Bottom Line

PRP therapy represents a meaningful advance in treating chronic foot and ankle tendon conditions — not because it’s a cure-all, but because it addresses the biological root cause of tendinopathy rather than masking symptoms. For patients with chronic plantar fasciitis, Achilles tendinopathy, or partial ligament tears who’ve exhausted conservative options, PRP offers a 70–80% chance of clinically meaningful improvement with a favorable risk profile and durable results.

The key is appropriate patient selection, ultrasound-guided injection technique, and realistic expectations about the 6–12 week timeline. PRP paired with mechanical offloading (good footwear, orthotics, stretching) consistently outperforms PRP alone. If you’ve been dealing with chronic heel or tendon pain and you’re wondering whether PRP is right for you, the best next step is an evaluation that includes diagnostic ultrasound to confirm the tissue pathology — then you’ll have the information you need to make an informed decision.

Sources

1. Shetty VD, et al. A study to compare the efficacy of corticosteroid therapy with platelet-rich plasma therapy in recalcitrant plantar fasciitis. J Foot Ankle Surg. 2021.
2. Fitzpatrick J, et al. The effectiveness of platelet-rich plasma in the treatment of tendinopathy: a meta-analysis of randomized controlled clinical trials. Am J Sports Med. 2017;45(1):226-233.
3. Vannini F, et al. PRP treatment in Achilles tendinopathy: systematic review and meta-analysis. Muscles Ligaments Tendons J. 2022.
4. Dragoo JL, et al. Platelet-rich plasma as a treatment for patellar tendinopathy: a double-blind, randomized controlled trial. Am J Sports Med. 2014.
5. Le ADK, et al. Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020. Int J Mol Sci. 2021;21(20):7794.